6533b7d2fe1ef96bd125f55c
RESEARCH PRODUCT
Crystal structure of (R)-6-fluoro-2-[(S)-oxiran-2-yl]chroman
Alexandre ClavelHugo LaureanoYoann Rousselinsubject
crystal structureCrystallographyStructure analysisStereochemistryAbsolute configurationEpoxideGeneral ChemistryCrystal structureCondensed Matter PhysicsData ReportsCrystalchemistry.chemical_compoundabsolute configurationColumn chromatographychemistryQD901-999General Materials Sciencenebivololdescription
The title compound, C11H11FO2, is a building block in the synthesis of the active pharmaceutical ingredient DL-nebivolol. The synthesis starting from the enantiomerically pure (R)-6-fluoro-4-oxo-3,4-dihydro-2H-chromene-2-carboxylic acid resulted in a mixture of two stereoisomers, namely (R)-6-fluoro-2-[(S)-oxiran-2-yl]chroman and (R)-6-fluoro-2-[(R)-oxiran-2-yl]chroman. The mixture was separated by column chromatography but only one stereoisomer crystallized. The X-ray structure analysis revealed that the solid consisted of theR,Sisomer. A similar procedure was repeated for (S)-6-fluoro-4-oxo-3,4-dihydro-2H-chromene-2-carboxylic acid and, in this case, theS,Risomer was produced as a crystalline solid. Thus, all four stereoisomers of the title epoxide were obtained and their absolute configuration was assigned. The crystal studied was refined as an inversion twin.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2015-08-01 | Acta Crystallographica Section E: Crystallographic Communications |